Spinal cord injuries commonly disrupt the transmission of motor commands from the brain to muscles and sever sensory feedback pathways essential for coordinating movement. Traditional rehabilitation methods often fail to restore this intricate sensorimotor loop, leaving patients unable to walk or sense limb positions accurately. The current study addresses these dual deficits through perilesional neuromodulation—implanting electrode arrays above and below the injured spinal segments to deliver patterned electrical stimulation designed to emulate natural spinal cord signals responsible for both voluntary muscle contraction and somatosensory feedback.

The clinical trial involved three participants paralyzed from the waist down following complete spinal cord lesions. Surgeons implanted miniature electrode arrays strategically placed proximal and distal to the injury site. Below-lesion stimulation focused on activating spinal circuits that command leg muscle activity, while stimulation above the lesion targeted sensory networks to simulate feedback from the lower limbs. This dual-site patterned stimulation represents the first successful attempt at integrating simultaneous motor facilitation and sensory substitution in humans with total paralysis, yielding encouraging functional outcomes.

Control over stimulation parameters was decentralized to the participants themselves through an innovative interface affectionately dubbed the “DJ board.” This control device, outfitted with an array of knobs and sliders, allowed subjects to modulate stimulation intensity, location, and frequency to achieve optimal flexion and relaxation patterns in leg muscles. This user-driven tuning not only personalized the therapeutic regimen but also empowered participants to engage dynamically in their own recovery, enhancing motivation and neuroplastic potential.

To refine these manually tuned patterns, researchers applied advanced machine learning algorithms capable of navigating the enormous parameter space inherent in spinal stimulation. Thomas Serre’s team at Brown trained predictive models correlating stimulation variables with desired muscle activation and sensory perception outcomes, enabling rapid convergence on highly effective, individualized neuromodulation schemes. This computational approach surmounted the limitations of trial-and-error optimization, ensuring precision in therapy delivery and robust adaptability.

Sensory feedback presented distinct challenges due to the disrupted ascending sensory pathways common in spinal injuries. Direct electrical stimulation of sensory nerves associated with the legs was impractical because these pathways were severed. Instead, the team adopted a sensory replacement strategy whereby stimulation above the lesion elicited perceivable sensations in intact dermatomes such as the chest or arms. Participants learned to reinterpret these artificial sensations as proxies for leg position and movement—an innovative form of sensory neuroplasticity that effectively substituted missing proprioceptive input.

Experimental validation demonstrated that participants could accurately identify knee angles based solely on varying intensities of sensations induced via spinal stimulation. Blindfolded during testing, subjects reported with high fidelity the flexion degree of their knees, signifying that the artificial sensory feedback was meaningful and actionable. This breakthrough has profound implications for restoring the sense of limb position, critical not only for walking but also for essential daily activities like transferring in and out of wheelchairs.

When combined, the motor and sensory stimulations facilitated remarkably coordinated walking motions on a treadmill, with participants harnessing stimulation to engage leg muscles while simultaneously perceiving foot contact with the ground. Supported by ceiling harnesses and physical therapy guidance, these individuals executed purposeful, rhythmic stepping, augmented by sensory cues that brought a new level of intentionality to their movements. Such integrated sensorimotor restoration significantly exceeds previous approaches that addressed movement or sensation in isolation.

Importantly, none of the participants reported adverse effects attributable to the electrode implants or electrical stimulation paradigms over the two-week in-hospital study. This safety profile paves the way for longitudinal studies targeting neurorehabilitation outside clinical settings. Researchers anticipate that prolonged use of coordinated spinal stimulation could catalyze neuroplastic remodeling, ultimately fostering improved voluntary motor control and functional independence in daily environments.

The multi-institutional collaboration drew on expertise spanning bioengineering, neurosurgery, cognitive neuroscience, and neurotechnology, exemplifying the power of interdisciplinary research to tackle complex biomedical challenges. This effort was supported by major federal funding entities including the Defense Advanced Research Projects Agency, the Department of Veterans Affairs, and the National Institutes of Health, underscoring the strategic importance of restoring sensorimotor function in spinal cord injury populations.

Looking forward, the team envisions augmenting their stimulation protocols with adaptive feedback loops and closed-loop control systems to further enhance precision and responsiveness. The integration of real-time sensory input with motor output modulation holds promise for developing next-generation neuroprosthetics capable of fully reinstating the seamless sensorimotor integration critical to human mobility. Such advances could revolutionize therapeutic paradigms for millions worldwide living with debilitating nervous system trauma.

This study marks a pivotal milestone in spinal cord injury research, illustrating the feasibility of bidirectional neurostimulation to replace lost sensorimotor function. By restoring both the ability to move and to perceive limb position, the researchers have brought us closer to the dream of fully regaining control and autonomy for individuals living with paralysis. This innovative approach is not merely an incremental advance but a transformative leap toward harnessing the power of neurotechnology to rewrite the lived experience of spinal cord injury.

Subject of Research: Restoration of sensorimotor functions in persons with complete spinal cord injury through perilesional electrical stimulation.

Article Title: Perilesional neuromodulation replaces lost sensorimotor function in persons with spinal cord injury

News Publication Date: 11-Mar-2026

Web References: http://dx.doi.org/10.1038/s41551-026-01627-5

Image Credits: Borton Lab / Brown University

Keywords: spinal cord injury, electrical stimulation, sensorimotor restoration, neurotechnology, neuromodulation, machine learning, rehabilitation, spinal neurosurgery, proprioception, neuroplasticity, bioengineering, clinical trial

The results emerge from a pilot clinical trial involving three adult volunteers diagnosed with varying degrees of SMA. Over a month-long period, regular sessions of targeted neurostimulation were administered, yielding notable improvements in motoneuron functionality, fatigue reduction, and marked enhancements in strength and ambulation. This pioneering research represents a significant leap forward, demonstrating for the first time that an engineered neurotechnology can counteract the degeneration of neural pathways and potentially restore cell function in a human neurodegenerative condition.

The complexity of SMA lies in its progressive nature, wherein the gradual deterioration of motor neurons culminates in severe physical limitations. “To effectively combat neurodegeneration, a dual approach is essential: halting the demise of neurons while rejuvenating the functionality of the surviving ones,” explained Dr. Marco Capogrosso, a leading researcher and assistant professor of neurosurgery at Pitt. This study posits a dual-pronged strategy that seeks to address the core issues of neural dysfunction, complementing existing neuroprotective therapies with a cutting-edge method that aims to restore neuronal capacity.

SMA is characterized by the gradual degeneration of motor neurons, the nerve cells responsible for controlling voluntary muscle movements. As motor neurons succumb to genetic mutations, patients experience debilitating muscle weakness and a range of motor deficits, including difficulties with locomotion, stair climbing, and even basic movements such as standing from a seated position. While therapeutic developments over the past decade, including gene replacement strategies and medications, have aimed to halt disease progression, this latest study aims to reverse the underlying neural deficits that contribute to SMA’s debilitating effects.

Prior research has indicated that the movement challenges associated with SMA can manifest before extensive motor neuron loss occurs, suggesting a critical role of spinal nerve circuit dysfunction in the disease’s initiation and symptomatology. Insights from previous animal model studies led by co-author Dr. George Mentis at Columbia University highlight that surviving motor neurons often receive diminished sensory feedback from nerve fibers returning information from the periphery to the central nervous system. Enhancing this feedback loop could improve the communication between the nervous system and muscles, potentially aiding voluntary movement and mitigating muscle wasting.

The researchers hypothesized that targeted epidural electrical stimulation could amplify sensory inputs directed toward motor neurons, which would reengage impaired neural circuits. These anticipated cellular modifications could translate into functional improvements in ambulatory capacity, offering hope not only for SMA patients but possibly also for individuals suffering from other neurodegenerative disorders.

Conducted as part of a pilot clinical trial, the study encompassed three adults diagnosed with milder forms of spinal muscular atrophy (Type 3 or 4). Participants underwent spinal cord stimulation (SCS) electrode implantation in the lower back, targeting sensory nerve roots exclusively. The treatment regimen involved five sessions per week over 29 days, with each session lasting approximately four hours, culminating in a total of 19 stimulation sessions.

Post-stimulation, the researchers executed a comprehensive battery of assessments, measuring variances in muscle strength, endurance, range of motion, fatigue levels, gait, and overall walking distance. These endpoints yielded illuminating results, evidencing functional improvements across various domains. Notably, all participants reported tangible benefits, with one patient expressing the newfound ability to walk unassisted from their residence to the research facility without succumbing to exhaustion.

Moreover, the study highlighted the capacity of neurostimulation to enhance participants’ scores on the 6-Minute Walk Test, a benchmark for measuring muscle endurance and fatigue. The study recorded an average increase of at least 20 meters amongst participants, starkly contrasting with a mean improvement of only 1.4 meters observed during a comparable three-month exercise program without spinal cord stimulation. Notably, patients who had undergone neuroprotective pharmacologic intervention for SMA over 15 months also experienced a median increase of just 20 meters, emphasizing the remarkable implications of electrical spinal cord stimulation.

The encouraging results reflected not only in functional assessments but also in the restored neural activity, signifying an increase in motor neurons’ capability to generate and relay electrical impulses to the muscles. As the research team elucidates, findings from this pilot study could pave the way for broader applications of neurostimulation techniques, extending beyond the domain of SMA treatment to include other neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) or Huntington’s disease, contingent on identifying appropriate neural targets in forthcoming studies.

Dr. Robert Friedlander, chair of neurosurgery at Pitt and a co-director of the UPMC Neurological Institute, also emphasized the potential for this neurostimulation therapy to usher in new treatment avenues: “Our results paint an optimistic picture for the application of this approach in treating a range of neurodegenerative diseases, as we look forward to the next phase of clinical trials aimed at evaluating the long-term efficacy and safety of spinal cord electrical stimulation in SMA patients.”

The groundbreaking research is the culmination of collaborative efforts involving a multidisciplinary team, including co-first authors Dr. Genis Prat-Ortega, Scott Ensel, and Serena Donadio from Pitt, alongside another wave of contributors from prestigious institutions such as Carnegie Mellon University and Columbia University. This investigation was funded by an exploratory research grant from F. Hoffmann–La Roche, with patent applications filed by several authors related to this innovative work.

As the medical community fully comprehends the gravity of neurodegenerative diseases, this research opens new frontiers in enhancing the quality of life for individuals facing disabilities tethered to such conditions. It underscores a paradigm shift in approaching the treatment of neurodegeneration, focusing not only on therapeutic safeguards against neuronal loss but also on rejuvenating and restoring the functionality of existing neural circuitry.

The compelling narrative emerging from this study encapsulates the relentless pursuit of effective treatments by pioneering medical researchers. The findings herald a transformative direction in the management of spinal muscular atrophy and underline the importance of clinical innovation in the realm of neurodegenerative diseases.

Subject of Research: Epidural spinal cord stimulation in spinal muscular atrophy
Article Title: First-in-human study of epidural spinal cord stimulation in individuals with spinal muscular atrophy
News Publication Date: 5-Feb-2025
Web References:
References:
Image Credits: UPMC and Pitt Health Sciences

Keywords: Neurodegeneration, spinal muscular atrophy, electrical stimulation, motor neurons, neurostimulation therapy, clinical trial, functional improvement, muscle strength, neuromuscular diseases, neuroprotective treatments, spinal cord injury, nerve function restoration.